Výsledky vyhledávání - "Renzo Realini"

Controlled Comparison of Tianeptine, Alprazolam and Mianserin in the Treatment of Adjustment Disorders with Anxiety and Depression

Autor: Guy Briole, Philippe Rombaut, Renzo Realini, Myriam Van Moffaert, André Vereecken, B. Troisfontaines, Michel Bataille, C. Mertens, Marc Ansseau, Andre De Nayer, Pierre André Fauchère, François Ferrero

Publikováno v: Human Psychopharmacology: Clinical and Experimental. 11:293-298

A multicentre study compared tianeptine (37·5 mg/day), an original psychotropic compound characterized by both antidepressant and anxiolytic potentials, with a reference antidepressant, mianserin (60 mg/day) and a reference anxiolytic, alprazolam (1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::15606ed3c0cf9cfe19b89bf14b5ccf46
https://doi.org/10.1002/(sici)1099-1077(199607)11:4<293::aid-hup771>3.0.co

Zobrazit plný text záznamu

A Double-Blind Comparison of Moclobemide and Thioridazine Versus Moclobemide and Placebo in the Treatment of Refractory, Severe Depression

Autor: Max Stabl, Robert Zochling, Edith Holsboer-Trachsler, Renzo Realini, Blajo Blajev, Giuseppe Bajetta, Martina Schaublin-Loidl, Antal Kasas

Publikováno v: Journal of Clinical Psychopharmacology. 15:41S-45S

In a multicenter study of 78 severely depressed inpatients (44 women and 34 men; age range, 23 to 70 years), the efficacy, onset of efficacy, and tolerability of the reversible monoamine oxidase-A inhibitor moclobemide (450 mg/day) in combination wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a37145adf21cd9d1b31c919f5a3690c8
https://doi.org/10.1097/00004714-199508001-00008

Zobrazit plný text záznamu

A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatients

Autor: Renzo Realini, Alain Martin, Michel Dierick, Luigi Ravizza

Publikováno v: Progress in neuro-psychopharmacologybiological psychiatry. 20(1)

1. This was a randomized, double-blind comparison of the efficacy and safety of venlafaxine and fluoxetine in outpatients with major depression. 2. Three hundred fourteen patients were randomly assigned to either venlafaxine 37.5 mg twice daily or fl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87116b81fdaed30d9e4cfb97508da209
https://pubmed.ncbi.nlm.nih.gov/8861177

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání